Glaxo's Malaria Vaccine Clears Final Scientific Hurdle

GlaxoSmithKline PLC’s malaria vaccine has cleared its final scientific hurdle, but it could still take up to a year before immunization programs begin in sub-Saharan Africa.

from WSJ.com: US Business http://ift.tt/1IqkT0o
via IFTTT